Patents/Assignees

Beijing Jiyuan Biological Technology Co., Ltd.

2 patents in portfolio

US12414966utility2025
Method of Treating Diabetes with FGF21 and GLP1 Double Gene-modified Cell
0 cites
US11752173utility2023
FGF21 and GLP1 Double Gene-modified Mesenchymal Stem Cell and Use in Treating a Metabolic Disease
0 cites